5 Stocks Set to Double Special Report: Only $1

Get in on our just-released 5 Stocks Set to Double Special Report. Each is the single favorite of a Zacks expert with the best chance to gain +100%.

Get in on our just-released 5 Stocks Set to Double Special Report. Each is the single favorite of a Zacks expert with the best chance to gain +100%.

The Best Dirt-Cheap Stocks to Buy Now

These 5 stocks are Zacks Strong Buys and have the top Style Scores for value. What more could you want? Tracey Ryniec brings us the latest Zacks Value Trader podcast.

These 5 stocks are Zacks Strong Buys and have the top Style Scores for value. What more could you want? Tracey Ryniec brings us the latest Zacks Value Trader podcast.

Top Analyst Reports for AstraZeneca, Qualcomm & FedEx

Today's Research Daily features new research reports on 16 major stocks, including AstraZeneca PLC (AZN), Qualcomm Inc. (QCOM) and FedEx Corp. (FDX).

Today's Research Daily features new research reports on 16 major stocks, including AstraZeneca PLC (AZN), Qualcomm Inc. (QCOM) and FedEx Corp. (FDX).

ETFs to Buy on Apple's Q2 Earnings Beat, Largest-Ever Buyback

Apple beat estimates on both earnings and revenues, and unveiled a record share buyback program amid the steep decline in iPhone sales.

Apple beat estimates on both earnings and revenues, and unveiled a record share buyback program amid the steep decline in iPhone sales.

3 Strong Stocks to Buy in May and Hold

The unknowns around the corner shouldn't deter investors since the last several years show how difficult the market timing game is. Investors who want to stay constantly exposed to stocks might consider buying these strong tech stocks in May.

The unknowns around the corner shouldn't deter investors since the last several years show how difficult the market timing game is. Investors who want to stay constantly exposed to stocks might consider buying these strong tech stocks in May.

New Strong Buy Stocks for May 3rd

This commercial-stage pharmaceutical company has seen the Zacks Consensus Estimate for its current year earnings increasing 9.9% over the last 60 days.

This commercial-stage pharmaceutical company has seen the Zacks Consensus Estimate for its current year earnings increasing 9.9% over the last 60 days.

AWS 5/3: Pre-Markets Blossom on Goldilocks Jobs Data

175K new jobs and +0.2% wage growth are both lower than expected but still clearly positive.

175K new jobs and +0.2% wage growth are both lower than expected but still clearly positive.

PFP 5/3: All Eyes On This Morning's Employment Report

Stocks closed solidly higher yesterday ahead of this morning's employment report.

Stocks closed solidly higher yesterday ahead of this morning's employment report.

Tesla: Buy More or Sell It Right Now?

Tesla shares have plunged this year as growth has stalled. Is this a buying opportunity or should you sell it? Tracey Ryniec discusses in the latest Zacks Market Edge podcast.

Tesla shares have plunged this year as growth has stalled. Is this a buying opportunity or should you sell it? Tracey Ryniec discusses in the latest Zacks Market Edge podcast.